- Home
- AEVA vs DNA Comparison
AEVA vs DNA Comparison
Compare AEVA & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- DNA
- Stock Information
- Founded
- AEVA 2019
- DNA 2008
- Country
- AEVA United States
- DNA United States
- Employees
- AEVA N/A
- DNA N/A
- Industry
- AEVA Auto Parts:O.E.M.
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AEVA Consumer Discretionary
- DNA Health Care
- Exchange
- AEVA Nasdaq
- DNA Nasdaq
- Market Cap
- AEVA 600.2M
- DNA 529.8M
- IPO Year
- AEVA N/A
- DNA N/A
- Fundamental
- Price
- AEVA $10.55
- DNA $9.17
- Analyst Decision
- AEVA Strong Buy
- DNA Strong Sell
- Analyst Count
- AEVA 4
- DNA 1
- Target Price
- AEVA $24.50
- DNA $9.00
- AVG Volume (30 Days)
- AEVA 2.1M
- DNA 1.3M
- Earning Date
- AEVA 11-05-2025
- DNA 11-06-2025
- Dividend Yield
- AEVA N/A
- DNA N/A
- EPS Growth
- AEVA N/A
- DNA N/A
- EPS
- AEVA N/A
- DNA N/A
- Revenue
- AEVA $15,154,000.00
- DNA $180,606,000.00
- Revenue This Year
- AEVA $107.53
- DNA N/A
- Revenue Next Year
- AEVA $104.37
- DNA $14.41
- P/E Ratio
- AEVA N/A
- DNA N/A
- Revenue Growth
- AEVA 89.90
- DNA N/A
- 52 Week Low
- AEVA $2.52
- DNA $5.00
- 52 Week High
- AEVA $38.80
- DNA $17.58
- Technical
- Relative Strength Index (RSI)
- AEVA 37.08
- DNA 42.97
- Support Level
- AEVA $9.04
- DNA $7.36
- Resistance Level
- AEVA $10.65
- DNA $8.54
- Average True Range (ATR)
- AEVA 0.98
- DNA 0.65
- MACD
- AEVA 0.04
- DNA 0.14
- Stochastic Oscillator
- AEVA 32.39
- DNA 55.62
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.